Topical sirolimus for treatment of a solitary angiokeratoma

Dermatol Ther. 2020 Nov;33(6):e13907. doi: 10.1111/dth.13907. Epub 2020 Jul 17.

Abstract

Angiokeratomas are benign vascular neoplasms that arise as solitary or multiple lesions, most commonly treated with excision, electrodessication, cryotherapy, or laser therapies. This case presents a young female whose solitary angiokeratoma was treated with topical 1% sirolimus cream, improving the appearance, symptoms, and size of the lesion. Topical sirolimus cream may be a noninvasive treatment option for angiokeratomas with fewer risks than standard therapy that may be feasible and preferable for some patients.

Keywords: angiokeratoma; pharmacology; quality of life; rapamycin; sirolimus; therapy-topical.

Publication types

  • Letter

MeSH terms

  • Angiokeratoma* / diagnosis
  • Angiokeratoma* / drug therapy
  • Female
  • Humans
  • Laser Therapy*
  • Sirolimus / adverse effects
  • Skin Neoplasms* / drug therapy

Substances

  • Sirolimus